Orange Book product · Brand (NDA)
LITHIUM CARBONATE
LITHIUM CARBONATE
At a glance
Jan 28, 1987
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 28, 1987
40 yr ago
Today
Pharmaceutical detail
Active ingredient
LITHIUM CARBONATE
Strength
150MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
NDA 017812
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1985LITHANEBrand (NDA)
NDA 018833 · BAYER PHARMS
- 1982ESKALITH CRBrand (NDA)
NDA 018152 · JDS PHARMS
- 1982LITHIUM CARBONATEBrand (NDA)
NDA 018558 · HIKMA
- —ESKALITHBrand (NDA)
NDA 016860 · NOVEN THERAP
- —LITHONATEBrand (NDA)
NDA 016782 · SOLVAY
- —LITHOBIDBrand (NDA)
NDA 018027 · ANI PHARMS
- —ESKALITHBrand (NDA)
NDA 017971 · JDS PHARMS
- —LITHIUM CARBONATEBrand (NDA)
NDA 016834 · PFIZER
- —LITHOTABSBrand (NDA)
NDA 016980 · SOLVAY
- 2017LITHIUM CARBONATEGeneric (ANDA)
ANDA 205663 · UNIQUE
- 2016LITHIUM CARBONATEGeneric (ANDA)
ANDA 205532 · HERITAGE PHARMA
- 2015LITHIUM CARBONATEGeneric (ANDA)
ANDA 204779 · UNIQUE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
